In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives

被引:78
|
作者
Robledo, S
Osorio, E
Muñoz, D
Jaramillo, LM
Restrepo, A
Arango, G
Vélez, I
机构
[1] Univ Antioquia, PECET, Medellin, Colombia
[2] Univ Antioquia, Grp Invest Sustancias Bioactivas, GISB, Medellin, Colombia
关键词
D O I
10.1128/AAC.49.4.1652-1655.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro and in vivo antileishmanial and cytotoxic activities of thymol and structural derivatives in comparison to those of Glucantime were studied. The results showed here suggest that thymol and hemisynthetic derivatives have promising antileishmanial potential and could be considered as new lead structures in the search for novel antileishmanial drugs.
引用
收藏
页码:1652 / 1655
页数:4
相关论文
共 50 条
  • [21] Synthesis of halogenated derivatives of thymol and their antimicrobial activities
    Ranjeet Kaur
    Mahendra P. Darokar
    Sunil Kumar Chattopadhyay
    Vinay Krishna
    Ateeque Ahmad
    Medicinal Chemistry Research, 2014, 23 : 2212 - 2217
  • [22] Chroman-4-one hydrazones derivatives: synthesis, characterization, and in vitro and in vivo antileishmanial effects
    Yulieth Upegui
    Karina Rios
    Wiston Quiñones
    Fernando Echeverri
    Rosendo Archbold
    Javier D. Murillo
    Fernando Torres
    Gustavo Escobar
    Iván D. Vélez
    Sara M. Robledo
    Medicinal Chemistry Research, 2019, 28 : 2184 - 2199
  • [23] Synthesis of novel thiazolylpyrazoline derivatives and evaluation of their antimicrobial activities and cytotoxicities
    Tabbi, Aouatef
    Kaplancikli, Zafer Asim
    Tebbani, Dahmane
    Yurttas, Leyla
    Canturk, Zerrin
    Atli, Ozlem
    Baysal, Merve
    Turan-Zitouni, Gulhan
    TURKISH JOURNAL OF CHEMISTRY, 2016, 40 (04) : 641 - 654
  • [24] Chroman-4-one hydrazones derivatives: synthesis, characterization, and in vitro and in vivo antileishmanial effects
    Upegui, Yulieth
    Rios, Karina
    Quinones, Wiston
    Echeverri, Fernando
    Archbold, Rosendo
    Murillo, Javier D.
    Torres, Fernando
    Escobar, Gustavo
    Velez, Ivan D.
    Robledo, Sara M.
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (12) : 2184 - 2199
  • [25] In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis
    Falzari, K
    Zhu, ZH
    Pan, DH
    Liu, HW
    Hongmanee, P
    Franzblau, SG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1447 - 1454
  • [26] Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies
    Anraku, Makoto
    Gebicki, Janusz M.
    Iohara, Daisuke
    Tomida, Hisao
    Uekama, Kaneto
    Maruyama, Toru
    Hirayama, Fumitoshi
    Otagiri, Masaki
    CARBOHYDRATE POLYMERS, 2018, 199 : 141 - 149
  • [27] In vitro anticancer, antioxidant, antimicrobial, antileishmanial, enzymes inhibition and in vivo anti-inflammatory activities of organotin(IV) derivatives of 4-bromophenoxyacetic acid
    Rahim, Shahnaz
    Sadiq, Abdul
    Javed, Aneela
    Kubicki, Maciej
    Kariuki, Benson
    Assad, Mohammad
    Muhammad, Niaz
    Fatima, Nighat
    Khan, Momin
    Alasmari, Abdullah F.
    Alasmari, Fawaz
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1313
  • [28] In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice
    Antimisiaris, SG
    Ioannou, PV
    Loiseau, PM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (05) : 647 - 652
  • [29] In Vitro and in Vivo Antileishmanial and Trypanocidal Studies of New N-Benzene- and N-Naphthalenesulfonamide Derivatives
    Galiana-Rosello, Cristina
    Bilbao-Ramos, Pablo
    Auxiliadora Dea-Ayuela, M.
    Rolon, Miriam
    Vega, Celeste
    Bolas-Fernandez, Francisco
    Garcia-Espana, Enrique
    Alfonso, Jorge
    Coronel, Cathia
    Eugenia Gonzalez-Rosende, M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 8984 - 8998
  • [30] Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives
    Prinsloo, Izak F.
    Zuma, Nonkululeko H.
    Aucamp, Janine
    N'Da, David D.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (02) : 383 - 398